J. Selfe

发表

Impact of fusion gene status versus histology on risk‐stratification for rhabdomyosarcoma: Retrospective analyses of patients on UK trials

A. Kelsey, J. Shipley, K. Thway, 2017, Pediatric blood & cancer.

Antitumor Activity of Sustained N-Myc Reduction in Rhabdomyosarcomas and Transcriptional Block by Antigene Therapy

J. Reis-Filho, R. Marchelli, R. Corradini, 2011, Clinical Cancer Research.

Germline and somatic genetic variants in the p53 pathway interact to affect cancer risk, progression and drug response

H. Carter, P. Pharoah, C. Turnbull, 2019, bioRxiv.

Distinct effects of ligand-induced PDGFRα and PDGFRβ signaling in the human rhabdomyosarcoma tumor cell and stroma cell compartments.

K. Pietras, J. Shipley, B. Brodin, 2013, Cancer research.

Aurora A kinase inhibition destabilizes PAX3-FOXO1 and MYCN and synergizes with Navitoclax to induce Rhabdomyosarcoma cell death.

D. Surdez, O. Delattre, B. Schäfer, 2019, Cancer research.

Fusion gene addiction: can tumours be forced to give up the habit?

J. Shipley, J. Selfe, 2017, The Journal of pathology.

Compartments in the Human Rhabdomyosarcoma Tumor Cell and Stroma Cell Signaling β and PDGFR α Distinct Effects of Ligand-Induced PDGFR

K. Pietras, J. Shipley, B. Brodin, 2013 .

IGF signalling in germ cells and testicular germ cell tumours: roles and therapeutic approaches

J. Shipley, J. Selfe, 2019, Andrology.

Molecular testing of rhabdomyosarcoma in clinical trials to improve risk stratification and outcome: A consensus view from European paediatric Soft tissue sarcoma Study Group, Children's Oncology Group and Cooperative Weichteilsarkom-Studiengruppe.

B. Schäfer, D. Hawkins, A. Kelsey, 2022, European journal of cancer.

Immunohistochemical Detection of Glypican-5 in Paraffin-embedded Material: An Optimized Method for a Novel Research Antibody

J. Shipley, K. Thway, J. Selfe, 2012, Applied immunohistochemistry & molecular morphology : AIMM.

Germline and Somatic Genetic Variants in the p53 Pathway Interact to Affect Cancer Risk, Progression, and Drug Response

H. Carter, P. Pharoah, C. Turnbull, 2021, Cancer Research.

IGF1R signalling in testicular germ cell tumour cells impacts on cell survival and acquired cisplatin resistance

R. Huddart, A. McIntyre, J. Shipley, 2018, The Journal of pathology.

Structural evolution of the BRCA1 genomic region in primates.

J. Selfe, E. Solomon, Joanna R. Morris, 2004, Genomics.

Endosialin expression in soft tissue sarcoma as a potential marker of undifferentiated mesenchymal cells

Robin L. Jones, C. Fisher, C. Isacke, 2016, British Journal of Cancer.

FGF7–FGFR2 autocrine signaling increases growth and chemoresistance of fusion‐positive rhabdomyosarcomas

A. Kelsey, M. Valenti, F. Raynaud, 2021, Molecular oncology.

Genomic imbalances in rhabdomyosarcoma cell lines affect expression of genes frequently altered in primary tumors: An approach to identify candidate genes involved in tumor development

G. Schaaf, M. Kool, Mohamed Hamdi, 2009, Genes, chromosomes & cancer.

Role for amplification and expression of glypican-5 in rhabdomyosarcoma.

Yong-jie Lu, P. Workman, K. Pritchard-Jones, 2007, Cancer research.

ATR Is a Therapeutic Target in Synovial Sarcoma.

Samuel E. Jones, A. Ashworth, S. Pettitt, 2017, Cancer research.

The Hippo effector TAZ (WWTR1) transforms myoblasts and TAZ abundance is associated with reduced survival in embryonal rhabdomyosarcoma

J. Shipley, G. Murray, J. Selfe, 2016, The Journal of pathology.

Dual Blockade of the PI3K/AKT/mTOR (AZD8055) and RAS/MEK/ERK (AZD6244) Pathways Synergistically Inhibits Rhabdomyosarcoma Cell Growth In Vitro and In Vivo

Khin Thway, Melanie Valenti, Torsten Pietsch, 2013, Clinical Cancer Research.

ABORIGINAL WOMEN AND THE LAW

Carol Thomas, J. Selfe, 1999 .

The long non-coding RNA MYCNOS-01 regulates MYCN protein levels and affects growth of MYCN-amplified rhabdomyosarcoma and neuroblastoma cells

A. Martins, J. Shipley, J. Selfe, 2018, BMC Cancer.

The Hippo transducer YAP1 transforms activated satellite cells and is a potent effector of embryonal rhabdomyosarcoma formation.

G. G. Galli, M. Delorenzi, F. Camargo, 2014, Cancer cell.

Glypican-3 is expressed in rhabdomyosarcomas but not adult spindle cell and pleomorphic sarcomas

C. Fisher, J. Shipley, K. Thway, 2011, Journal of Clinical Pathology.

Genomic Classification and Clinical Outcome in Rhabdomyosarcoma: A Report From an International Consortium

Jun S. Wei, S. Sindiri, M. Yohe, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

MicroRNA and gene co-expression networks characterize biological and clinical behavior of rhabdomyosarcomas

O. Delattre, J. Shipley, J. Selfe, 2017, Cancer letters.

Biological Role and Clinical Implications of MYOD1L122R Mutation in Rhabdomyosarcoma

A. Kelsey, J. Merks, J. Shipley, 2023, Cancers.

Chemosensitivity profiling of osteosarcoma tumour cell lines identifies a model of BRCAness

Samuel E. Jones, Amaya Garcia Munoz, A. Ashworth, 2018, Scientific Reports.

Role for the Histone Demethylase KDM4B in Rhabdomyosarcoma via CDK6 and CCNA2: Compensation by KDM4A and Apoptotic Response of Targeting Both KDM4B and KDM4A

O. Rossanese, J. Shipley, J. Blagg, 2021, Cancers.

Genomic and Epigenetic Changes Drive Aberrant Skeletal Muscle Differentiation in Rhabdomyosarcoma

B. Schäfer, J. Shipley, R. Alaggio, 2023, Cancers.

Targeted resequencing of pediatric rhabdomyosarcoma: report from the Children’s Oncology Group, the Children’s Cancer and Leukaemia Group, The Institute of Cancer Research UK, and the National Cancer Institute.

J. Khan, Jun S. Wei, S. Skapek, 2018 .

Combination EZH2 inhibition and retinoic acid treatment promotes differentiation and apoptosis in rhabdomyosarcoma cells

Ian G. Reddin, W. Tapper, A. Kelsey, 2023, bioRxiv.

Automated Quantification Of Blood Microvessels In Hematoxylin And Eosin Whole Slide Images

Yinyin Yuan, A. Kelsey, J. Shipley, 2021, COMPAY@MICCAI.

The Hippo transducer YAP1 transforms activated satellite cells and is a potent effector of embryonal rhabdomyosarcoma formation.

M. Delorenzi, F. Camargo, A. Wagers, 2014, Cancer cell.

Distinct effects of ligand-induced PDGFRα and PDGFRβ signaling in the human rhabdomyosarcoma tumor cell and stroma cell compartments.

K. Pietras, J. Shipley, B. Brodin, 2013, Cancer research.

Distinct Effects of Ligand-Induced PDGFR and PDGFR Signaling in the Human Rhabdomyosarcoma Tumor Cell and Stroma Cell Compartments

K. Thway, J. Selfe, E. Missiaglia, 2013 .

Dual Blockade of the PI3K/AKT/mTOR (AZD8055) and RAS/MEK/ERK (AZD6244) Pathways Synergistically Inhibits Rhabdomyosarcoma Cell Growth In Vitro and In Vivo

M. Valenti, A. K. de Haven Brandon, R. Ruddle, 2013, Clinical Cancer Research.

Pharmacological EZH2 inhibition combined with retinoic acid treatment promotes differentiation and apoptosis in rhabdomyosarcoma cells

R. Pengelly, K. Thway, J. Selfe, 2023, Clinical Epigenetics.